Zika: Researchers identify how the virus infects placenta

The finding showed that Zika virus could infect Hofbauer cells -- placental macrophages -- in cell culture

The United States reported its first case in February
The United States reported its first case in February
IANS New York
Last Updated : May 28 2016 | 3:10 PM IST

A team of researchers led by Indian-origin scientists have discovered that the deadly Zika virus can infect and replicate in immune cells from the placenta, without killing them.

According to the researchers, little was known about how the virus was replicating in placenta and in what cell type.

The finding showed that Zika virus could infect Hofbauer cells -- placental macrophages -- in cell culture.

Hofbauer cells are foetally derived, in contrast with other immune cells found in the placenta called decidual macrophages, which are maternally derived.

They are thought to be more tolerant and less prone to inflammatory responses than other immune cells, the researchers said.

However, signs of antiviral and inflammatory responses were detected in infected Hofbauer cells.

"Host genetics and non-viral factors, including nutrition and microbiota, as well as timing may be influencing infectivity," said one of the researchers Mehul Suthar, assistant professor at Emory University in the US.

Also, the level of viral replication was found different from donor to donor, hinting that some women's placentae may be more susceptible to viral infection than others.

"Not every pregnant woman who is infected by Zika transmits the virus to her foetus," Suthar added.

In addition, the virus could infect another type of placental cell, called cytotrophoblasts, but only after a couple days delay and not as readily.

The study, published in the journal Cell Host & Microbe, may explain how the virus can pass through the placenta of a pregnant woman, on its way to infect developing brain cells in her foetus.

"A better understanding of these factors could allow the design of preventive measures, and eventually antiviral therapies," Suthar noted.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 28 2016 | 2:02 PM IST

Next Story